Literature DB >> 2589013

Myelopathy of unknown etiology. A clinical follow-up and MRI study of 57 cases.

J Martí-Fàbregas1, J M Martínez, I Illa, A Escartín.   

Abstract

After a careful differential diagnosis of 264 consecutive cases of spinal cord syndrome seen over a period of 10 years, no diagnosis was reached in 72 patients. Of these cases, known as myelopathy of unknown etiology (MUE), 57 were followed-up for a mean of 2.33 years, 50 being chronic cases and 7 acute cases. Diagnosis was reached in 29 (58%) of the 50 chronic cases, the remaining 21 (42%) still being of unknown etiology. The most frequent diagnosis was either definite or probable multiple sclerosis (MS). Magnetic resonance imaging (MRI) was of great value in detecting asymptomatic brain lesions. We conclude that after a long clinical follow-up and the use of MRI we were able to diagnose more than half the previously MUE patients.

Entities:  

Mesh:

Year:  1989        PMID: 2589013     DOI: 10.1111/j.1600-0404.1989.tb03909.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis.

Authors:  E Paolino; E Fainardi; P Ruppi; M R Tola; V Govoni; I Casetta; V C Monetti; E Granieri; M Carreras
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

2.  Multiple lesions in cerebral white matter in two young adults with thoracic extramedullary tumours.

Authors:  F Salvi; M Mascalchi; R Plasmati; R Michelucci; F Calbucci; G Dal Pozzo; C A Tassinari
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

3.  Acute myelopathy of unknown aetiology: a clinical, neurophysiological and MRI study of short- and long-term prognostic factors.

Authors:  V Martinelli; G Comi; M Rovaris; M Filippi; B Colombo; T Locatelli; A Campi; M Rodegher; N Canal
Journal:  J Neurol       Date:  1995-08       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.